Mojca Unk

5.6k total citations
14 papers, 193 citations indexed

About

Mojca Unk is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mojca Unk has authored 14 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Mojca Unk's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Mojca Unk is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Mojca Unk collaborates with scholars based in Slovenia, Switzerland and United States. Mojca Unk's co-authors include Martina Vrankar, Robert M. Lorence, Hovav Nechushtan, Jens C. Eickhoff, Urban Simončič, Andrej Studen, Jin‐Yuan Shih, Philippe Carrière, Alessandra Curioni‐Fontecedro and Vito Spataro and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Cancers.

In The Last Decade

Mojca Unk

11 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mojca Unk Slovenia 6 134 117 69 24 23 14 193
Eric Thunnissen Netherlands 5 129 1.0× 122 1.0× 56 0.8× 26 1.1× 62 2.7× 6 223
Laura Ginocchi Italy 8 119 0.9× 67 0.6× 27 0.4× 47 2.0× 26 1.1× 17 183
Fiorella Ruatta Italy 7 123 0.9× 101 0.9× 25 0.4× 31 1.3× 40 1.7× 26 200
Guzel Mukhametshina Russia 7 143 1.1× 91 0.8× 46 0.7× 26 1.1× 12 0.5× 15 190
J. De Langen Netherlands 7 124 0.9× 99 0.8× 32 0.5× 28 1.2× 22 1.0× 18 159
Silvana Acquafredda Italy 6 159 1.2× 94 0.8× 19 0.3× 42 1.8× 40 1.7× 8 237
Jian Zhong China 9 114 0.9× 104 0.9× 75 1.1× 63 2.6× 45 2.0× 23 256
Waleed Kian Israel 10 111 0.8× 125 1.1× 28 0.4× 42 1.8× 30 1.3× 34 193
Dingwei Ye China 7 139 1.0× 61 0.5× 52 0.8× 77 3.2× 15 0.7× 12 200
Ina Valeria Zurlo Italy 6 105 0.8× 89 0.8× 15 0.2× 36 1.5× 40 1.7× 24 191

Countries citing papers authored by Mojca Unk

Since Specialization
Citations

This map shows the geographic impact of Mojca Unk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Unk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Unk more than expected).

Fields of papers citing papers by Mojca Unk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Unk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Unk. The network helps show where Mojca Unk may publish in the future.

Co-authorship network of co-authors of Mojca Unk

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Unk. A scholar is included among the top collaborators of Mojca Unk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Unk. Mojca Unk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Hochmair, Maximilian J., Mojca Unk, Timur Cerić, et al.. (2024). Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability. BMC Proceedings. 18(S3). 2–2.
3.
Pižem, Jože, Emanuela Boštjančič, Andrej Zupan, et al.. (2024). Multifocal vascular neoplasm with an EWSR1::NFATC2 gene fusion and progression to epithelioid angiosarcoma – a case report. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(6). 1175–1181. 1 indexed citations
4.
5.
Unk, Mojca, Barbara Jezeršek Novaković, & Srdjan Novaković. (2023). Molecular Mechanisms of Gastrointestinal Stromal Tumors and Their Impact on Systemic Therapy Decision. Cancers. 15(5). 1498–1498. 7 indexed citations
6.
7.
8.
9.
Gašljević, Gorana, et al.. (2021). NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker—The Role of RNA Sequencing in the Diagnostic Procedure. International Journal of Surgical Pathology. 30(3). 273–277. 5 indexed citations
10.
Vrankar, Martina, Mojca Unk, Andrej Studen, et al.. (2020). [ 18 F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab. Radiology and Oncology. 54(3). 285–294. 59 indexed citations
11.
Milačić, Radmila, Janja Vidmar, Maja Čemažar, et al.. (2019). Monolithic chromatography on conjoint liquid chromatography columns for speciation of platinum-based chemotherapeutics in serum of cancer patients. Journal of Trace Elements in Medicine and Biology. 57. 28–39. 8 indexed citations
12.
Vrankar, Martina & Mojca Unk. (2018). Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy. Radiology and Oncology. 52(4). 365–369. 34 indexed citations
13.
Peters, Solange, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, et al.. (2018). Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program. Journal of Thoracic Oncology. 13(12). 1897–1905. 66 indexed citations
14.
Peters, Solange, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, et al.. (2017). Activity of afatinib in heavily pretreated patients (pts) with HER2 mutation-positive (HER2m+) advanced non-small cell lung cancer (NSCLC): findings from a global named patient use (NPU) program. Annals of Oncology. 28. v484–v485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Thunnissen Breakdown of academic impact, for papers by Laura Ginocchi Breakdown of academic impact, for papers by Fiorella Ruatta Breakdown of academic impact, for papers by Guzel Mukhametshina Breakdown of academic impact, for papers by J. De Langen Breakdown of academic impact, for papers by Silvana Acquafredda Breakdown of academic impact, for papers by Jian Zhong Breakdown of academic impact, for papers by Waleed Kian Breakdown of academic impact, for papers by Dingwei Ye Breakdown of academic impact, for papers by Ina Valeria Zurlo
Rankless by CCL
2026